Fenwick represented Movano Inc., a health-focused technology company dedicated to enhancing the quality of life for people affected by chronic health conditions, including diabetes, in its bridge round which closed at $12.5 million. Since its founding in 2018, Movano has raised nearly $30 million to create a wearable non-invasive continuous glucose monitor that is painless, smart and simple.
The additional funding will be used to expand both internal and external testing efforts. The capital will also help accelerate the process of miniaturizing Movano’s technology into a single chip that can fit inside a wearable. More information can be obtained from Movano’s announcement.
The Fenwick transaction team was led by corporate partner Michael Esquivel, counsel Malcolm Katz and associates Shweta Kumar and Alyssa Zhang.